Skip to content

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04387136
Enrollment
53
Registered
2020-05-13
Start date
2020-10-14
Completion date
2021-02-04
Last updated
2022-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Pain, Acute, Anesthesia

Brief summary

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

Detailed description

This is a level I randomized prospective outcomes study comparing two groups of patients. Within 15-30 minutes of planned wake-up Group 1 will receive 30 mcg of sublingual sufentanil and group 2 will not receive sublingual sufentanil.

Interventions

15-30 minutes prior to planned emergence from anesthesia patients will either receive 30 mcg of sublingual sufentanil dispensed by the anesthesia provider.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\- Adult patients undergoing outpatient ambulatory surgery undergoing general anesthesia for orthopedic surgery

Exclusion criteria

* non-english speaking patients * patients who have allergy or intolerance to the study drugs or derivatives

Design outcomes

Primary

MeasureTime frameDescription
Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival2 hoursPain is assessed on a scale of 0-10 (whole numbers). A score of 0 being no pain, 10 being maximum imaginable pain. Data collected upon arrival to Post-Anesthesia Care Unit (PACU).

Secondary

MeasureTime frameDescription
Opioid Use in Recovery Room2 hoursOpioid medication type and dose will be recorded and converted to milligram morphine equivalents. Outcome is reported as the total milligram morphine equivalents of opioid medication used in the recovery room.
OBAS Score2 hoursOverall Benefit of Analgesic Score (OBAS) is a 7-item multi-dimensional survey that assesses analgesia benefits. Items are scored on a scale from 0 (minimal) to 4 (maximal). Total score is a sum of the 7 item scores with question 7 scored as 4 minus the patient reported number. Total scores range from 0 to 28 with lower scores representing greater benefit from analgesic therapy.

Countries

United States

Participant flow

Participants by arm

ArmCount
Sublingual Sufentanil
Participants in this arm will receive the intervention. Sublingual Sufentanil: 15-30 minutes prior to planned emergence from anesthesia patients will either receive 30 mcg of sublingual sufentanil dispensed by the anesthesia provider.
26
Control
Participants in this arm will not receive an intervention.
27
Total53

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Deviation by SOC staff12

Baseline characteristics

CharacteristicSublingual SufentanilControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants1 Participants3 Participants
Age, Categorical
Between 18 and 65 years
24 Participants26 Participants50 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
12 Participants9 Participants21 Participants
Sex: Female, Male
Male
14 Participants18 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 25
other
Total, other adverse events
4 / 251 / 25
serious
Total, serious adverse events
0 / 250 / 25

Outcome results

Primary

Initial Numeric Rating Scale (NRS) Pain Score Upon Arrival

Pain is assessed on a scale of 0-10 (whole numbers). A score of 0 being no pain, 10 being maximum imaginable pain. Data collected upon arrival to Post-Anesthesia Care Unit (PACU).

Time frame: 2 hours

ArmMeasureValue (MEDIAN)
Sublingual SufentanilInitial Numeric Rating Scale (NRS) Pain Score Upon Arrival4 score on a scale
ControlInitial Numeric Rating Scale (NRS) Pain Score Upon Arrival4 score on a scale
Secondary

OBAS Score

Overall Benefit of Analgesic Score (OBAS) is a 7-item multi-dimensional survey that assesses analgesia benefits. Items are scored on a scale from 0 (minimal) to 4 (maximal). Total score is a sum of the 7 item scores with question 7 scored as 4 minus the patient reported number. Total scores range from 0 to 28 with lower scores representing greater benefit from analgesic therapy.

Time frame: 2 hours

ArmMeasureValue (MEDIAN)
Sublingual SufentanilOBAS Score1.0 score
ControlOBAS Score3.0 score
Secondary

Opioid Use in Recovery Room

Opioid medication type and dose will be recorded and converted to milligram morphine equivalents. Outcome is reported as the total milligram morphine equivalents of opioid medication used in the recovery room.

Time frame: 2 hours

ArmMeasureValue (MEDIAN)
Sublingual SufentanilOpioid Use in Recovery Room7.5 mg (morphine equivalent)
ControlOpioid Use in Recovery Room15.0 mg (morphine equivalent)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026